BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Argus Health
Cerilliant
Healthtrust
Cipla
Chubb
Boehringer Ingelheim
Federal Trade Commission
Mallinckrodt
Covington

Generated: January 16, 2018

DrugPatentWatch Database Preview

CEFTAZIDIME Drug Profile

« Back to Dashboard

Drug patent expirations by year for CEFTAZIDIME
Pharmacology for CEFTAZIDIME

US Patents and Regulatory Information for CEFTAZIDIME

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acs Dobfar CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 062640-002 Nov 20, 1985 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 065482-001 May 28, 2010 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Acs Dobfar CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 062640-001 Nov 20, 1985 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare CEFTAZIDIME SODIUM IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 063221-001 Apr 29, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 065481-001 May 28, 2010 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare CEFTAZIDIME SODIUM IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 063221-003 Apr 29, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Acs Dobfar CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 062640-003 Nov 20, 1985 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Acs Dobfar CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 062640-004 Feb 3, 1992 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 065481-003 May 28, 2010 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 065481-002 May 28, 2010 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Cantor Fitzgerald
Accenture
Argus Health
Federal Trade Commission
Chubb
McKinsey
Cerilliant
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot